Royal Biologics
Royal Biologics is a pioneering leader in orthobiologic and wound care research and development. The company is dedicated to delivering innovative biologic solutions that enhance healing and improve patients' quality of life. With a comprehensive product portfolio, Royal focuses on patient-centered care, innovation, excellence, integrity, and compassion. It continuously develops and launches new products, setting benchmarks for quality and effectiveness, and remains at the forefront of healthcare innovation.
Industries
Nr. of Employees
small (1-50)
Royal Biologics
401 Hackensack Avenue, Suite 604, Hackensack, NJ 07601
Patents
Products
Autologous bone grafting and fusion kit
Point-of-care kit that integrates autologous cell harvesting, PRP/PRFM processing and graft materials to create live-cell grafts intraoperatively.
Centrifuge-based platelet-rich fibrin system
System for producing platelet-rich fibrin membranes and gels from patient blood using defined centrifugation steps for use as grafts or mixed with bone graft material.
PRP concentration system
Closed sterile PRP device enabling adjustable hematocrit, buffy‑coat targeting and rapid cycles to yield concentrated platelet products.
DMSO-free cryopreserved cellular bone matrix
Cryopreserved allograft combining demineralized cortical and cancellous bone with preserved cell populations using a DMSO-free cryoprotectant.
Bioactive composite bone graft
Moldable composite combining carbonate apatite anorganic bone mineral, bioactive glass and type I collagen for osteoconductive bone regeneration and use as a bone graft extender.
Synthetic 3D porous scaffold (hyper-crosslinked polymer)
Highly porous, biocompatible, biodegradable synthetic scaffold with standardized pore architecture and forms (granules, sheets, blocks) designed to be resorbed and replaced by new bone.
Autologous bone grafting and fusion kit
Point-of-care kit that integrates autologous cell harvesting, PRP/PRFM processing and graft materials to create live-cell grafts intraoperatively.
Centrifuge-based platelet-rich fibrin system
System for producing platelet-rich fibrin membranes and gels from patient blood using defined centrifugation steps for use as grafts or mixed with bone graft material.
PRP concentration system
Closed sterile PRP device enabling adjustable hematocrit, buffy‑coat targeting and rapid cycles to yield concentrated platelet products.
DMSO-free cryopreserved cellular bone matrix
Cryopreserved allograft combining demineralized cortical and cancellous bone with preserved cell populations using a DMSO-free cryoprotectant.
Bioactive composite bone graft
Moldable composite combining carbonate apatite anorganic bone mineral, bioactive glass and type I collagen for osteoconductive bone regeneration and use as a bone graft extender.
Synthetic 3D porous scaffold (hyper-crosslinked polymer)
Highly porous, biocompatible, biodegradable synthetic scaffold with standardized pore architecture and forms (granules, sheets, blocks) designed to be resorbed and replaced by new bone.
Services
Customer support via online form, phone and email for product inquiries and ordering.
Program to support external research projects and evidence generation in wound care and orthobiologics.
Web-based portal for distributor account access and order management (password-protected).
Customer support via online form, phone and email for product inquiries and ordering.
Program to support external research projects and evidence generation in wound care and orthobiologics.
Web-based portal for distributor account access and order management (password-protected).
Expertise Areas
- Orthobiologics
- Wound-care biologic therapies
- Autologous cell therapies and point-of-care grafting
- PRP and PRFM preparation
Key Technologies
- Platelet-rich plasma (PRP) processing
- Platelet-rich fibrin membrane (PRFM) production
- Bone marrow aspiration and trephine extraction
- DMSO-free cryoprotectant formulations
News & Updates
Join Royal Wound-X and experts for a discussion on advanced healing technologies at SAWC Fall 2024.
Join Royal Wound-X and experts for a discussion on advanced healing technologies at SAWC Fall 2024.